BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 3591059)

  • 1. [Second-look and third-look laparotomies in follow-up of ovarian cancer. A critical review of 6 years' experience].
    Schneider J; Erasun F; Hervas JL; Miñambres JL
    Zentralbl Gynakol; 1987; 109(4):235-42. PubMed ID: 3591059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The second-look operation in advanced ovarian cancer].
    Richter P; Lotze W
    Zentralbl Gynakol; 1987; 109(4):228-34. PubMed ID: 2438864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radical peritonectomy in 37 patients with stage II and III ovarian cancer].
    Capretti PG; Zeppieri MC; Simonetti A; Rosato S; Lovotti D; Battaini A; Capretti G; Agnes Pradelli B
    Minerva Chir; 2004 Jun; 59(3):233-41. PubMed ID: 15252388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The therapeutic value of second-look laparotomy in advanced ovarian carcinoma].
    Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
    Zentralbl Gynakol; 1988; 110(22):1443-8. PubMed ID: 3223119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical therapy of ovarian carcinoma].
    Sevelda P
    Wien Med Wochenschr; 1996; 146(1-2):18-22. PubMed ID: 8835491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
    Friedman RL; Eisenkop SM; Wang HJ
    Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personal experiences in the treatment of stage III and IV ovarian cancer].
    Welponer F; Delucca A; Messini S
    Gynakol Rundsch; 1990; 30 Suppl 1():45-8. PubMed ID: 2079298
    [No Abstract]   [Full Text] [Related]  

  • 9. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
    Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
    Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
    Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of ovarian cancer with combined operative, radiologic and cytostatic therapy].
    Ullrich D; Grimm D; Rothe K; Glaser FH; Heider KM; Woraschk A; Hänsgen G; Köhler L; Schöneich V
    Zentralbl Gynakol; 1985; 107(10):628-33. PubMed ID: 3160189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current aspects of therapy of ovarian cancer. Surgical therapy of epithelial ovarian cancer at the Göttingen University Gynecologic Clinic. A retrospective analysis of 82 patients 1981-1984].
    Grospietsch G; Kühnle H; Knappe G; Rümelin B; Kuhn W
    Geburtshilfe Frauenheilkd; 1986 Sep; 46(9):588-94. PubMed ID: 3770409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Our experience in treating ovarian tumors with borderline malignancy].
    Ivanov S; Kŭrlov T; Ivanov S
    Akush Ginekol (Sofiia); 2000; 39(1):39-41. PubMed ID: 10826337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-look surgery (SLO) in the management of carcinoma of the ovary.
    Hernádi Z; Sápy T; Lukácskó L; Borsos A
    Acta Chir Hung; 1997; 36(1-4):128-9. PubMed ID: 9408314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of radical surgical technics in gynecology exemplified by ovarian and cervix cancer].
    Käser O
    Geburtshilfe Frauenheilkd; 1989 Dec; 49(12):1025-30. PubMed ID: 2693186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
    Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The value of reoperation in the treatment of ovarian cancer].
    Meier W; Römisch M; Hepp H
    Geburtshilfe Frauenheilkd; 1993 Jan; 53(1):30-4. PubMed ID: 8440455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.